Medtronic gets expanded FDA approval for heart failure device

04/11/2012 | Reuters

Medtronic has received expanded FDA approval for use of its CRT-D device in patients with mild symptoms of heart failure. The implantable cardioverter defibrillator, which transmits electrical signals to cardiac muscles to enhance blood pumping in the heart, had been previously approved for treating moderate-to-severe heart failure patients.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY